Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital

Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital

An increased mortality risk was observed in patients with cancer during the first wave of COVID-19. Here, we describe determinants of mortality in patients with solid cancer comparing the first and second waves of COVID-19. A retrospective analysis encompassing two waves of COVID-19 (March–May 2020;...

Full description

Bibliographic Details
Main Authors: Yien Ning Sophia Wong, Christopher C. T. Sng, Diego Ottaviani, Grisma Patel, Amani Chowdhury, Irina Earnshaw, Alasdair Sinclair, Eve Merry, Anjui Wu, Myria Galazi, Sarah Benafif, Gehan Soosaipillai, Neha Chopra, Rebecca Roylance, Heather Shaw, Alvin J. X. Lee
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Cancers
Subjects:
COVID-19
SARS-CoV-2 infection
solid cancer
risk factors
systemic anti-cancer therapy
co-morbidity
Online Access:https://www.mdpi.com/2072-6694/13/23/6085

Internet

https://www.mdpi.com/2072-6694/13/23/6085

Similar Items